Cardinal Health (NYSE:CAH) subsidiary Cordis recently revealed a voluntary recall of its Precise Pro RX nitinol carotid stent system based on issues with shaft separation during stent deployment.
The issue was discovered after the company received complaints about separation difficulties with the stent, which is indicated for use in patients with stenotic lesions of the carotid artery, and investigated the issue independently.
Cordis said it discovered that affected lots of the Precise stent system had an “increased frequency of incidents of deployment difficulty and in some instances outer member shaft separation resulting in inability to deploy the stent or partial stent deployment,” according to its urgent safety recall notice.
